Investment Stage

Focus Areas

About Investor

Sumner Anderson is a Partner at Deerfield Management who focuses on investments in BioTech, Pharmaceuticals, Health IT, and Health & Hospital Services at Pre-seed, Seed, Series A, and Series B stages, with investment ranges typically between $10.0M and $50.0M. His verified work background includes joining Deerfield in 2012 as a member of the Therapeutics team, providing extensive research and analysis on individual companies operating in the healthcare industry, before transitioning to the Public Structured Finance team in 2019. Prior to Deerfield, Anderson was a research analyst covering pharmaceuticals at Millennium Management, and before that, he was a Managing Director in healthcare investment banking at Wells Fargo Securities and a pharmaceutical analyst in Global Equities at Citadel Investment Group. He holds an A.B. in History and Economics from Harvard University, and an M.B.A. with an emphasis in Finance and Accounting from New York University.